You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

DAY101

Showing 1 - 25 of 7,582
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Low-grade Glioma Trial (Tovorafenib)

Available
  • Low-grade Glioma
  • (no location specified)
Feb 23, 2023

Recurrent Langerhans Cell Histiocytosis, Refractory Langerhans Cell Histiocytosis Trial (Biopsy, Biospecimen Collection,

Not yet recruiting
  • Recurrent Langerhans Cell Histiocytosis
  • Refractory Langerhans Cell Histiocytosis
  • Biopsy
  • +3 more
  • (no location specified)
Dec 22, 2022

Recurrent Langerhans Cell Histiocytosis, Refractory Langerhans Cell Histiocytosis Trial in United States (Biospecimen

Recruiting
  • Recurrent Langerhans Cell Histiocytosis
  • Refractory Langerhans Cell Histiocytosis
  • Biospecimen Collection
  • +8 more
  • Wilmington, Delaware
  • +3 more
Apr 28, 2023

Craniopharyngioma, Child, Craniopharyngioma, Recurrent Craniopharyngioma Trial in San Francisco (Nivolumab, DAY101)

Not yet recruiting
  • Craniopharyngioma, Child
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Jul 15, 2022

Low-grade Glioma Trial (DAY101, Chemotherapeutic Agent)

Not yet recruiting
  • Low-grade Glioma
  • DAY101
  • Chemotherapeutic Agent
  • (no location specified)
Oct 3, 2022

Melanoma, Solid Tumor Trial in Korea, Republic of, Spain, United States (DAY101, Pimasertib Hydrochloride)

Recruiting
  • Melanoma
  • Solid Tumor
  • DAY101
  • Pimasertib Hydrochloride
  • Los Angeles, California
  • +13 more
Jul 27, 2022

Age-Related Macular Degeneration Trial in Sydney, Melbourne, Tel Aviv (VOY-101)

Recruiting
  • Age-Related Macular Degeneration
  • VOY-101
  • Sydney, New South Wales, Australia
  • +3 more
Oct 17, 2023

Low-grade Glioma, Advanced Solid Tumor Trial in Worldwide (DAY101)

Recruiting
  • Low-grade Glioma
  • Advanced Solid Tumor
  • DAY101
  • San Francisco, California
  • +35 more
May 25, 2022

Progressive Supranuclear Palsy Trial in United States (TPN-101, 100 mg/day, TPN-101, 200 mg/day, TPN-101, 400 mg/day)

Recruiting
  • Progressive Supranuclear Palsy
  • TPN-101, 100 mg/day
  • +3 more
  • La Jolla, California
  • +9 more
Mar 10, 2022

Herpes Labialis Trial in Germany (drug, behavioral, procedure)

Active, not recruiting
  • Herpes Labialis
  • HDIT101 (blinded therapy)
  • +5 more
  • Berlin, Germany
  • +4 more
Jan 26, 2023

Advanced Cancer Trial in Oxford (CXD101)

Active, not recruiting
  • Advanced Cancer
  • Oxford, Oxfordshire, United Kingdom
    Oxford University Hospitals NHS Trust
Jan 6, 2022

Amyotrophic Lateral Sclerosis, Frontotemporal Dementia Trial in Worldwide (TPN-101, 400 mg/day, Placebo)

Recruiting
  • Amyotrophic Lateral Sclerosis
  • Frontotemporal Dementia
  • TPN-101, 400 mg/day
  • Placebo
  • Orange, California
  • +4 more
Mar 9, 2022

Ulcerative Colitis Trial in Worldwide (drug, other, combination product)

Completed
  • Ulcerative Colitis
  • AMT-101 (oral)
  • +2 more
  • Tbilisi, Georgia
  • +17 more
Sep 13, 2022

Healthy Trial (FMX101)

Completed
  • Healthy
  • (no location specified)
Sep 9, 2019

Healthy Trial (FMX-101)

Completed
  • Healthy
  • (no location specified)
Aug 26, 2019

Psoriasis Trial in United States (PPC-06 400 mg QD, PPC-06 400 mg BID, PPC-06 600 mg)

Completed
Has Results
  • Psoriasis
  • PPC-06 400 mg QD
  • +3 more
  • Glendale, Arizona
  • +73 more
Mar 23, 2022

Multiple Myeloma, Refractory Multiple Myeloma Trial (procedure, drug, radiation)

Withdrawn
  • Multiple Myeloma
  • Refractory Multiple Myeloma
  • nonmyeloablative allogeneic hematopoietic stem cell transplantation
  • +7 more
  • (no location specified)
Jan 4, 2023

Advanced or Metastatic Solid Tumors Trial in Birtinya, Frankston (KGX101- Cohort 1, KGX101- Cohort 2, KGX101- Cohort 3)

Not yet recruiting
  • Advanced or Metastatic Solid Tumors
  • KGX101- Cohort 1
  • +7 more
  • Birtinya, Queensland, Australia
  • +1 more
Oct 3, 2023

Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Aurora, Seattle (drug, procedure,

Active, not recruiting
  • Acute Biphenotypic Leukemia
  • +18 more
  • Aurora, Colorado
  • +2 more
Dec 28, 2022

Healthy Trial in Tel Aviv (Anti-human CCL24 mAb (CM-101), Placebo)

Completed
  • Healthy
  • Anti-human CCL24 monoclonal antibody (CM-101)
  • Placebo
  • Tel Aviv, Israel
    Tel Aviv Sourasky Medical Center
Sep 7, 2023

Alopecia Areata Trial in Randwick (OR-101 (Single ascending dose), OR-101 (Food effect), OR-101 (Multiple ascending dose))

Not yet recruiting
  • Alopecia Areata
  • OR-101 (Single ascending dose)
  • +3 more
  • Randwick, New South Wales, Australia
    SCIENTIA Clinical Research Ltd
Sep 13, 2023

Smoking Cessation, Nicotine Dependence Trial in Gières (NFL-101, Placebo)

Completed
  • Smoking Cessation
  • Nicotine Dependence
  • Gières, Isère, France
    Eurofins Optimed
Oct 18, 2023

Staphylococcus Aureus Bloodstream Infection Trial (XJ101 for Injection, Placebo)

Not yet recruiting
  • Staphylococcus Aureus Bloodstream Infection
  • XJ101 for Injection
  • Placebo
  • (no location specified)
Aug 25, 2023

Age-Related Macular Degeneration Trial in Toronto (NG101 AAV gene therapy)

Not yet recruiting
  • Age-Related Macular Degeneration
  • NG101 AAV gene therapy
  • Toronto, Ontario, Canada
    Vitreous Retina Macula Specialists of Toronto
Aug 2, 2023

Eye Diseases, Presbyopia, Refractive Errors Trial in Newport Beach (Aceclidine + Brimonidine, Aceclidine)

Recruiting
  • Eye Diseases
  • +5 more
  • Newport Beach, California
    Site #101
Jul 7, 2023